Dr. Hamdi Abdel-Azim, a professor of oncology, the results of a recent study presented results for the first time in the annual conference of the American Cancer Society in Chicago, and showed the possibility of prevention of diseases, breast cancer success rate of 65%, using the drug has been used before for the treatment of patients.
The Abdel-Azim said the study represents the second generation of studies on this topic, was conducted under the auspices of the National Cancer Institute of Canada with other groups in conjunction with Harvard University and published the first time in June 2011, and included 4560 patients from the women most at risk of developing breast cancer, and who been identified over the age of 60 years,...